55 results
8-K
EX-99.2
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
) ** Approved for radiolucent gallstones
5 Clinical Programs 2024 Strategic Goals to Build Value INDUSTRY LEADING TEAM DELIVERING REMARKABLE TREATMENTS
8-K
EX-99.1
86be6ml8wwqn84wl2om4
13 Oct 23
Other Events
4:16pm
8-K
EX-99.2
sgs 0016p1qz4x3apd
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
dzcj srbup
6 Jun 22
Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors
8:32am